Trial Profile
Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2009
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms RIGHT
- 04 Jun 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 25 Sep 2005 Interim results were reported at ASCO 2005.
- 24 Sep 2005 New trial record.